InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Gangloff Scott A., Chief Technology Officer. Insider active across 1 companies, notably Akero Therapeutics, Inc.. Aggregated, 2 disclosures have been recorded. Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
5,088 shares
Common Stock
SEC:0001193125-25-312111·
5,088 shares
Common Stock
SEC:0001193125-25-312111:0·
2 of 2 declarations
About Gangloff Scott A.
Scott A. Gangloff is the Chief Technology Officer at Akero Therapeutics, Inc. He oversees the company's technological initiatives, ensuring innovation and process efficiency. His role is crucial for the development of new therapeutic solutions.
